Patent · US Expired

Use of adeno-associated viruses for decreasing the radiotherapy-induced or chemotherapy- induced resistance in cancer patients

US6743423B1 · kind B1 · utility

1Cited by

0References

9Claims

0Family size

Assignee

DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS · DE

Inventors

Mangus Von Knebel-Doeberitz · Heidelberg, DE
Petra Klein-Bauernschmitt · Heidelberg, DE
Harald Zur Hausen · Heidelberg, DE
Jorg Schlehofer · Leimen, DE

Key dates

Filing date	Mar 22, 2001
Grant date	Jun 1, 2004
Priority date	—
Expiry date	Mar 22, 2021

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14132
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of adeno-associated viruses for decreasing the radiotherapy-induced or chemotherapy-induced resistance in patients who suffer from a cancer which is to be treated by radiotherapy or chemotherapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.